Agomab Therapeutics NV (AGMB)

CIK 2020932 · other company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Agomab Therapeutics NV.

Recent SEC filings

FiledFormAccession number
Sep 11, 20266-K0001104659-26-107117
Aug 10, 20266-K0001104659-26-093390
Aug 6, 20266-K0001104659-26-091992
Jun 23, 20266-K0001104659-26-076819
May 27, 20266-K0001104659-26-066590
May 15, 2026SCHEDULE 13G0001104659-26-062718
May 15, 2026SCHEDULE 13G0001172661-26-002216
May 6, 2026SCHEDULE 13G0001193125-26-207455
Apr 24, 20266-K0001104659-26-048615
Apr 23, 202620-F0001104659-26-047872
Apr 16, 2026SCHEDULE 13G0001213900-26-044365
Mar 18, 202630001104659-26-030841
Mar 18, 202630001104659-26-030839
Mar 18, 202630001104659-26-030837
Mar 18, 202630001104659-26-030833
Mar 18, 202630001104659-26-030838
Mar 18, 202630001104659-26-030834
Mar 18, 202630001104659-26-030840
Mar 18, 202630001104659-26-030835
Mar 18, 202630001104659-26-030842
Mar 18, 202630001104659-26-030843
Mar 18, 202630001104659-26-030836
Mar 11, 2026S-80001104659-26-026472
Mar 6, 2026SCHEDULE 13G0000315066-26-000646
Mar 5, 20266-K0001104659-26-024095